Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Pfister

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.
The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.
Cancers of the Head & Neck|May 17, 2019
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancerShrujal S Baxi, Talya Salz, Han Xiao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancerSeng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Oral Oncology|May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancerJennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Cancer|March 3, 2015
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysisCaitriona B O'Neill, Shrujal S Baxi, Coral L Atoria, et al.
Head & Neck|May 2, 2009
Predictors of outcome for advanced-stage supraglottic laryngeal cancerIan Ganly, Snehal G Patel, Jeanette Matsuo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2007
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancersNancy Y Lee, William O'Meara, Kelvin Chan, et al.
Cancer|June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancerEric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.
The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.
Cancers of the Head & Neck|May 17, 2019
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancerShrujal S Baxi, Talya Salz, Han Xiao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancerSeng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.
Oral Oncology|May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancerJennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Cancer|March 3, 2015
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysisCaitriona B O'Neill, Shrujal S Baxi, Coral L Atoria, et al.
Head & Neck|May 2, 2009
Predictors of outcome for advanced-stage supraglottic laryngeal cancerIan Ganly, Snehal G Patel, Jeanette Matsuo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2007
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancersNancy Y Lee, William O'Meara, Kelvin Chan, et al.
Cancer|June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancerEric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Pageof 17